Bacteriostatic water — sterile water for injection with 0.9% benzyl alcohol added as a preservative — inhibits microbial growth in the vial across the multi-dose research window. This distinguishes it from plain sterile water (labelled single-use only) and makes it the operational default for lyophilized-peptide reconstitution where the diluent will be in the vial for days or weeks of bench work.
Definition
Bacteriostatic water for injection, abbreviated BWFI or bacteriostatic water, is a USP-monographed diluent comprising water for injection with 0.9% (9 mg/mL) benzyl alcohol added as a preservative. Benzyl alcohol is bacteriostatic — it inhibits bacterial growth at the in-vial concentration rather than killing organisms outright — and provides preservation across the labelled 28-day in-use stability window after first puncture of the rubber stopper. Plain sterile water for injection (SWFI) lacks the preservative and is labelled for single-use only; any volume drawn from a SWFI vial that is not immediately used must be discarded.
For research-peptide reconstitution, the preservative-containing diluent is the operational default because most peptide research protocols involve drawing successive doses from a single reconstituted vial across days or weeks of an experiment. The bacteriostatic property prevents microbial contamination from compromising the experimental compound between draws, assuming aseptic technique on each puncture.
How bacteriostatic water is used in peptide research
The standard research-handling protocol calls for chilled bacteriostatic water added down the inside wall of the sealed peptide vial, allowed to dissolve the lyophilisate by gentle swirl rather than agitation, and refrigerated between uses. Recommended reconstitution volumes for common research peptides (typically 1 mL to 5 mL per 10 mg vial depending on the desired working concentration) and the corresponding insulin-syringe conversion math are covered in the reconstitution guide. Post-reconstitution stability and the additional considerations for compounds known to be sensitive to benzyl alcohol or to repeated freeze-thaw cycling are covered in the peptide storage guide.
Benzyl alcohol is not universally inert toward all peptide chemistries — a small set of compounds show measurable degradation or aggregation in the presence of the preservative — but it is the standard diluent for the great majority of research peptides supplied as lyophilisates. Where a compound is known to be incompatible with benzyl alcohol the vendor or the published handling literature will specify plain SWFI with single-use draw or an alternative buffer.
Related terms
- Lyophilized
- Aliquot
- Freeze-thaw cycle
- Cold chain
- Sterile water for injection (SWFI)
- Benzyl alcohol
- Reconstitution
Where bacteriostatic water appears in the Ronin workflow
Every lyophilized peptide in the Ronin catalog is reconstituted with bacteriostatic water before use. The recommended diluent volume, syringe-IU conversion, and aseptic-handling protocol for each compound are in the per-product accordion on the product page (Reconstitution and laboratory handling section) and consolidated in the reconstitution guide.
References
- United States Pharmacopeia <1231> Water for Pharmaceutical Purposes — monograph defining Water for Injection and Bacteriostatic Water for Injection specifications and in-use stability.
- USP Bacteriostatic Water for Injection monograph — composition (water for injection plus 0.9% benzyl alcohol), labelled storage and in-use windows.
- FDA Compounding Guidance — multi-dose vial handling and in-use stability for preserved injectable diluents.
Glossary entries describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. Every compound in the Ronin catalog is sold strictly for laboratory and research use only.